A Study to Determine the Safety, Tolerability, and Pharmacokinetics of GDC-0310 in Healthy Volunteers
Status:
Completed
Trial end date:
2017-06-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of single and multiple
orally ascending doses of GDC-0310 administered in healthy participants as 4 parts including
Part 1- a single dose (SD) part using a powder-in-capsule (PIC) formulation, Part 2- a
multiple dose (MD) part using a PIC formulation, Part 3- a SD part using a solution
formulation, and Part 4- a MD part using a solution formulation. Effects of food on
pharmacokinetics (PK) will also be explored.